Acrolein consumption induces systemic dyslipidemia and lipoprotein modification - Wikidata - wikimedia - TriplyDB

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

http://www.wikidata.org/entity/Q28749663

about

sameAs

Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry Exposure to acrolein by inhalation causes platelet activation Uremic toxins: some thoughts on acrolein and spermine.Molecular mechanisms of aldehyde toxicity: a chemical perspective.Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.Acrolein exposure is associated with increased cardiovascular disease risk.Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?Acrolein impairs the cholesterol transport functions of high density lipoproteins.Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1 Aldehyde Detection in Electronic Cigarette Aerosols Prevalence of dyslipidaemia and risk factors in Chinese coal miners: a cross-sectional survey study.Contribution of PPARγ in modulation of acrolein-induced inflammatory signaling in gp91phox knock-out mice.Acrolein Can Cause Cardiovascular Disease: A Review.Environmental Determinants of Cardiovascular Disease.Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.Impact of Electronic Cigarettes on the Cardiovascular System.Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase.Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice.Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross- sectional cohort: Cardiovascular Injury due to Tobacco Use study.

P2860

Q26999354-0590904A-88B5-4409-BA4C-901266818498 Q28749132-AC11F43F-A025-4D4C-8B60-F732ADC290E1 Q30244334-AE983A1A-6869-4395-936F-22BC2BB65254 Q33932854-CE962200-A51F-4E04-83CA-F554E0EE0FDC Q34248329-D6EF27FB-2132-4F0B-B70F-6634A22C8C06 Q34756881-4AC1FEC0-6873-4114-9593-EF01F34B79F5 Q35026283-506AFDCD-EFBA-46F7-8960-E401A762A122 Q35154969-191CA90E-04BB-4DAB-933A-F58E603F7AD7 Q35301213-3F72BD1C-1159-4C62-8CA3-134CA36A6EE4 Q36294446-FFCAA069-E47C-45FF-A3D3-4521B9DEFA18 Q37734544-EFDA54EF-C4FF-4F98-AE08-D0609ECCD544 Q38611341-F12AABB4-DC73-4093-91CE-3DB90F07B8FA Q38855544-07EB54CC-09B2-4663-B905-78C8C92AC973 Q39085410-8ECD8EC4-98A7-46B5-A313-73808DAD466C Q39419369-6503E587-301E-42CC-A673-5BEB289154F6 Q39604465-F6AB4CA1-B351-4B2E-8E48-CC6C212D7B40 Q42373718-35190956-DAEB-42E4-826A-006328DD86FD Q42397268-3277BB2A-9704-489E-BE15-24D80672373F Q46483039-B66207D0-CD40-43BD-967E-4D934BC9EA04 Q51015141-0355C77B-7274-452E-A2AF-19EC811B1302 Q52618061-BEBE8D29-1170-4590-BAF2-E3E1875725F9

P2860

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

http://www.wikidata.org/entity/Q28749663

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@ast

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@en

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@nl

type

label

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@ast

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@en

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@nl

prefLabel

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@ast

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@en

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@nl

P1433

Q28749663-60A7E26C-C597-44CA-8065-970B923E4552

P1476

Q28749663-36685D88-8EAF-44E5-AEE3-378DCC2A467D

P2093

Q28749663-17E395E9-07CD-4ED0-986C-FED3050F772D

Q28749663-1E2F70E1-0BE0-4DB4-81F6-63B891DB293A

Q28749663-2A8384AD-1C54-4358-B805-BB04C3BCD192

Q28749663-51CDFF79-D315-43F0-A15A-320E99D70878

Q28749663-86C433DF-C012-421C-A3B8-EF13048BC7C3

Q28749663-AB14FEDA-5314-412C-9B93-8AA3ACB156C7

Q28749663-B1AFC9E8-EABB-4D76-8570-86C010B1C689

P2860

Q28749663-0016DC14-D851-4645-B85B-E29D6813FD6B

Q28749663-04184E18-5736-4626-A51A-B207FAA60929

Q28749663-15F172DB-04A3-415D-AD36-0A48274EF59B

Q28749663-27B4C44A-C850-4517-92B5-2C521A9CBCC7

Q28749663-3365C8CF-CC63-460C-A582-392D15FEF6FB

Q28749663-343FE440-9D60-4F4B-A398-E118CBCC556E

Q28749663-48E03704-0EF1-4E3B-8B01-A51E4F53BBE3

Q28749663-4982E86F-2188-4287-8134-FC90D6D40A1F

Q28749663-5358E683-53C2-484B-AC11-6EACD7914DC0

Q28749663-56A17C29-329C-4EE8-B58B-C4F18DF96D35

P304

Q28749663-4821D4DA-855D-4CE0-8B43-218E368F0E98

P31

Q28749663-683F608C-B332-4065-AC99-D43DCBC96CB8

P356

Q28749663-6CBAD560-8080-4002-9B43-566B5C46FAB6

P407

Q28749663-8BAB20A8-ECFF-4390-9F43-D9032D66ABCE

P433

Q28749663-184ADFC4-0E5A-4315-BDA2-09339F5ECB12

P478

Q28749663-3C771DB9-BBB4-4478-BA43-E2A3FD75B668

P50

Q28749663-572FA2A0-0687-472A-B758-000818E19B9C

Q28749663-6870AA23-9EAD-4543-94BE-524558C2840B

Q28749663-B779E6AD-3584-4303-B3EF-E055068FF7AC

Q28749663-C5CF7FCF-2F31-41E6-88DE-26D25D8B4BC0

P577

Q28749663-0CE34F10-B586-4AA2-A4C5-C1F6DA7A0DEA

P5875

Q28749663-9FC107BA-384F-41CF-BC8F-260AB95FF8B6

P698

Q28749663-F62148AB-BE15-491E-8944-AB2B37DFF0ED

P921

Q28749663-03D2E595-8996-4276-BDCB-A6CBE89C8797

Q28749663-C45B08C0-1324-4827-B52A-F4B7DDF21AD1

P932

Q28749663-15F414FE-43CE-4E47-A3C1-AF60A3094885

P356

J.TAAP.2009.12.010

P1433

Toxicology and Applied Pharmacology

P1476

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification

@en

P2093

Aruni Bhatnagar

http://www.w3.org/2001/XMLSchema#string

Daniel J Conklin

http://www.w3.org/2001/XMLSchema#string

Elena Vladykovskaya

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Lesgards

http://www.w3.org/2001/XMLSchema#string

Sanjay Srivastava

http://www.w3.org/2001/XMLSchema#string

SiQi Liu

http://www.w3.org/2001/XMLSchema#string

Tadeja Rezen

http://www.w3.org/2001/XMLSchema#string

P2860

Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice

Species differences in the metabolism of olefins: implications for risk assessment

Cyclophosphamide cystitis--identification of acrolein as the causative agent

Thermally oxidized oil increases the expression of insulin-induced genes and inhibits activation of sterol regulatory element-binding protein-2 in rat liver

Characterization of acrolein-glycerophosphoethanolamine lipid adducts using electrospray mass spectrometry

Role of leptin in the neuroendocrine response to fasting

Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TAAP.2009.12.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40773647

http://www.w3.org/2001/XMLSchema#string

P698

20034506

http://www.w3.org/2001/XMLSchema#string

P921

P932

2922677

http://www.w3.org/2001/XMLSchema#string